ZYME - 3 Top Biotech Picks for 2025
When it comes to astronomical returns in investing, one of the most important factors -- aside from buying the right company -- is buying your shares early, when ordinary people have never heard of the stock. Of course, there is a danger in being too early. But you can guard against that danger by starting with just a small investment and adding more shares when you see more and more success.
This sort of early-stage investing is very similar to the venture capital industry. Maybe one or two of three stocks will fail, but those small losses are irrelevant if and when the third stock has a 1,000% return. Here's why Ontrak (NASDAQ: OTRK), Nano-X Imaging (NASDAQ: NNOX), and Zymeworks (NYSE: ZYME) are all strong candidates for stratospheric outperformance by 2025.
Image source: Getty Images.